PHARMAC considering multiple new treatments from Takeda

19 September 2022 - Pharmac has initiated consultation today on a provisional bundle deal with Takeda to fund vedolizumab for people ...

Read more →

Can the proposed listing of two medicines from the same supplier really be called a bundle deal?

16 September 2022 -  On Wednesday, PHARMAC announced a "medicines bundle to provide more treatment options for New Zealanders." ...

Read more →

PHARMAC announces medicines bundle to provide more treatment options for New Zealanders

14 September 2022 - PHARMAC is considering funding two medicines as part of a new bundle agreement that would offer ...

Read more →

PHARMAC opens door to funding Keytruda in 'biggest step forward in treatment of lung cancer'

6 July 2022 - Keytruda has been called a 'miracle' drug, and there's a glimmer of hope now for those ...

Read more →

PHARMAC considering funding new medicines for lung cancer

6 July 2022 - PHARMAC is seeking proposals from pharmaceutical suppliers for medicines that could treat New Zealanders with lung ...

Read more →

PHARMAC proposing to widen access to funded medicines

14 February 2022 - PHARMAC has issued a consultation today on proposals to widen access to two medicines, rituximab and zoledronic ...

Read more →

PHARMAC seeks feedback on a biosimilar brand of adalimumab being considered for funding

26 August 2021 - PHARMAC is considering awarding Principal Supply to a biosimilar brand of adalimumab (Amgevita) from 1 February ...

Read more →

Proposal for the supply of primidone and gabapentin

22 June 2021 - PHARMAC is seeking additional feedback on a proposal to change the funded brands of primidone tablets ...

Read more →

Proposal to fully fund Mercilon 28 for oral contraception

26 February 2021 - PHARMAC is seeking feedback on a proposal to increase the subsidy to fully fund ethinyloestradiol 20 ...

Read more →

Proposal to widen access to rituximab for treatment of membranous nephropathy

4 December 2020 - PHARMAC is seeking feedback on a proposal to widen access to rituximab. ...

Read more →

Proposal to widen access to valganciclovir for transplant patients

12 November 2020 - PHARMAC is seeking feedback on a proposal to widen access to valganciclovir. ...

Read more →

Proposal to widen access to sirolimus for lymphovascular malformations and tuberous sclerosis complex complications

2 October 2020 - PHARMAC is seeking feedback on a proposal to widen funded access to sirolimus from 1 February ...

Read more →

Proposal to fund emicizumab for people with haemophilia A

18 September 2020 - PHARMAC is seeking feedback on a proposal to fund emicizumab (Hemlibra), a new treatment for people with ...

Read more →

Proposal for new calcineurin inhibitor listings on the Pharmaceutical Schedule

11 August 2020 - As part of PHARMAC’s Annual Tender process, PHARMAC is proposing to list two new medicines on ...

Read more →

Proposal to fund an additional brand of budesonide with eformoterol

30 July 2020 - PHARMAC is seeking feedback on a proposal to fund an additional brand (DuoResp Spiromax) of two ...

Read more →